SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-08-109621
Filing Date
2008-05-09
Accepted
2008-05-09 15:13:12
Documents
5
Period of Report
2008-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d10q.htm 10-Q 483107
2 SUMMARY OF 2008 BONUS PLAN dex1055.htm EX-10.55 2356
3 CERTIFICATION OF CEO PURSUANT TO RULE 13A-14(A) OR RULE 15D-14(A) dex311.htm EX-31.1 7794
4 CERTIFICATION OF CFO PURSUANT TO RULE 13A-14(A) OR RULE 15D-14(A) dex312.htm EX-31.2 7811
5 CERTIFICATION OF CEO AND CFO PURSUANT TO 18 U.S.C. SECTION 1350 dex321.htm EX-32.1 3995
  Complete submission text file 0001193125-08-109621.txt   506581
Mailing Address 345 OYSTER POINT BLVD. SOUTH SAN FRANCISCO CA 94080
Business Address 345 OYSTER POINT BLVD. SOUTH SAN FRANCISCO CA 94080 650.635.1100
Monogram Biosciences, Inc. (Filer) CIK: 0001094961 (see all company filings)

IRS No.: 943234479 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-30369 | Film No.: 08818023
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
Assistant Director 1